By John Kruzel WASHINGTON (Reuters) – The U.S. Supreme Court declined on Monday to hear a bid by Michael Cohen to revive a lawsuit accusing Donald Trump and various former federal officials of returning him to prison in 2020 in retaliation for penning a book critical of Trump, who was president at the time. Cohen, …
US Supreme Court won’t hear Michael Cohen bid to revive suit against Donald Trump Read More »
By Dominique Patton PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R). French public investment bank Bpifrance is expected to become a minority shareholder, taking a stake of around …
Sanofi in exclusive talks with CD&R over sale of $17 billion Opella Read More »
By Ateeq Shariff (Reuters) – Stock markets in the Gulf were mixed on Monday amid rising geopolitical tensions in the region, while investors await more companies to report quarterly results. Hundreds of Beirut residents fled their homes late on Sunday, as Israel prepared to attack sites linked to the financial operations of Lebanon’s Hezbollah group. …
Gulf bourses end mixed on regional tensions, Q3 earnings Read More »
(Reuters) – Catalent CEO Alessandro Maselli said on Monday he will remain at the helm of the U.S.-based contract drugmaker after it is acquired by Novo Holdings, the controlling shareholder of weight-loss drug manufacturer Novo Nordisk. Maselli’s open letter comes on the back of criticism over Novo Holding’s $16.5-billion acquisition of Catalent, which U.S. consumer …
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings’ buyout Read More »
WASHINGTON (Reuters) – Vice President Kamala Harris and former President Donald Trump remain in a tight contest across seven battleground states with just over two weeks until the Nov. 5 U.S. presidential election, a Washington Post/Schar School opinion poll showed on Monday. Democratic former prosecutor Harris led among likely voters in Georgia 51% to 47%, …
Harris, Trump in dead heat across swing states in Washington Post poll Read More »
(Reuters) – Novo Nordisk said on Monday an oral version of its drug semaglutide, helped significantly reduce the risk of cardiovascular events in patients in a late-stage study. The drug, Rybelsus, helped reduce the risk of these events, including cardiovascular death, non-fatal heart attack and stroke, by 14% compared to placebo, meeting the main goal …
Novo Nordisk’s oral diabetes drug cuts heart-related risks by 14% in study Read More »
By Nuha Sharaf, Mohammed Torokman and Ismael Khader BURIN, West Bank (Reuters) – Palestinian olive farmer Khitam Najjar dreams of just one season where she can gather the harvest in peace. But it’s not this year. As she and her son approached their olive groves near the village of Burin in the occupied West Bank …
Attacked by settlers and blocked by soldiers, Palestinians face grim olive harvest Read More »
By Sam Tobin LONDON (Reuters) -BHP is cynically trying to avoid its responsibility for Brazil’s worst environmental disaster, lawyers representing thousands of victims told London’s High Court on Monday, as a lawsuit worth up to 36 billion pounds ($47 billion) began. More than 600,000 Brazilians, 46 local governments and around 2,000 businesses are suing BHP …
BHP trying to avoid responsibility over Brazilian dam collapse, UK court told Read More »
TAIPEI (Reuters) -A U.S. and a Canadian warship sailed through the sensitive Taiwan Strait together on Sunday, less than a week after China conducted a new round of war games around the island, with Beijing denouncing the mission as “disruptive”. The U.S. navy, occasionally accompanied by ships from allied countries, transits the strait around once …
US, Canadian navies sail through Taiwan Strait week after war games Read More »
By Amina Niasse NEW YORK (Reuters) – As CVS Health’s new CEO David Joyner steps into the top job after Karen Lynch’s quick departure on Friday, Wall Street analysts and some investors are questioning whether he has the right experience to turn around the Aetna health insurance business as it struggles with high medical costs. …
Analysis-Can the new CVS CEO handle the Aetna challenge? Read More »
